StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
BDPT

BioAdaptives, Inc.

BDPT OTC Pharmaceutical Preparations EDGAR ↗
$0.00
+0.00 +37.93%

Key statistics

from XBRL data in SEC filings
Market cap
$48.0K
Revenue (TTM)
$23.8K
Net income (TTM)
-$1.47M
EPS (TTM)
$-0.14
P/E ratio
Dividend yield
Free cash flow
-$534K
Cash
$73.6K
Total assets
$136K
Gross margin
69.8%
52-week range
$0.00 – $0.07

Recent SEC filings

40 most recent
Annual, quarterly & current reports
10-Q Quarter ended 2026-03-31 May 15, 2026 10-K Fiscal year ended 2025-12-31 Apr 14, 2026 10-Q Quarter ended 2025-09-30 Nov 14, 2025 10-Q Quarter ended 2025-06-30 Aug 14, 2025 10-Q Quarter ended 2025-03-31 May 13, 2025 10-K Fiscal year ended 2024-12-31 Apr 15, 2025 8-K Regulation FD disclosure Mar 18, 2025 8-K Director or officer change Feb 7, 2025 8-K Regulation FD disclosure Dec 5, 2024 8-K Regulation FD disclosure Nov 27, 2024 8-K Regulation FD disclosure; Other events Nov 20, 2024 10-Q Quarter ended 2024-09-30 Nov 19, 2024 8-K Regulation FD disclosure; Other events Oct 30, 2024 10-Q Quarter ended 2024-06-30 Aug 19, 2024 8-K Director or officer change; Regulation FD disclosure May 22, 2024 10-Q Quarter ended 2024-03-31 May 17, 2024 8-K Changed accountants May 14, 2024 10-K Fiscal year ended 2023-12-31 Apr 10, 2024 10-Q Quarter ended 2023-09-30 Nov 13, 2023 10-Q Quarter ended 2023-06-30 Aug 11, 2023 10-Q Quarter ended 2023-03-31 May 12, 2023 8-K Director or officer change; Amended charter or bylaws Apr 6, 2023 10-K Fiscal year ended 2022-12-31 Mar 31, 2023 10-Q Quarter ended 2022-09-30 Nov 14, 2022 10-Q Quarter ended 2022-06-30 Aug 12, 2022 8-K Regulation FD disclosure Jun 14, 2022 10-Q Quarter ended 2022-03-31 May 12, 2022 10-K Fiscal year ended 2021-12-31 Mar 31, 2022 8-K Entered a material agreement; Regulation FD disclosure Feb 3, 2022 8-K Regulation FD disclosure Jan 21, 2022 8-K Regulation FD disclosure Dec 16, 2021 10-Q Quarter ended 2021-09-30 Nov 10, 2021 8-K Regulation FD disclosure Aug 27, 2021 10-Q Quarter ended 2021-06-30 Aug 12, 2021 8-K Other events Jul 22, 2021 8-K Entered a material agreement; Director or officer change; Regulation FD disclosure Jun 11, 2021 10-Q Quarter ended 2021-03-31 May 14, 2021 10-K Fiscal year ended 2020-12-31 Mar 30, 2021 10-Q Quarter ended 2020-09-30 Nov 16, 2020 10-Q Quarter ended 2020-06-30 Aug 13, 2020